187 related articles for article (PubMed ID: 31464629)
21. Once daily oral extended-release hydrocodone as analgesia following tibial plateau leveling osteotomy in dogs.
Heffernan AE; Katz EM; Sun Y; Rendahl AK; Conzemius MG
Vet Surg; 2018 May; 47(4):516-523. PubMed ID: 29635873
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the analgesic efficacy of perioperative firocoxib and tramadol administration in dogs undergoing tibial plateau leveling osteotomy.
Davila D; Keeshen TP; Evans RB; Conzemius MG
J Am Vet Med Assoc; 2013 Jul; 243(2):225-31. PubMed ID: 23822079
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of firocoxib for the treatment of pain associated with soft tissue surgery in dogs under field conditions in Japan.
Kondo Y; Takashima K; Matsumoto S; Shiba M; Otsuki T; Kinoshita G; Rosentel J; Gross SJ; Fleishman C; Yamane Y
J Vet Med Sci; 2012 Oct; 74(10):1283-9. PubMed ID: 22673062
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs (Sus scrofa domestica).
Kleine S; Hampton CE; Smith C; Bussieres G; Mulon PY; Seddighi R; Cox S; Smith J
J Vet Pharmacol Ther; 2023 Sep; 46(5):269-275. PubMed ID: 37493273
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the safety of long-term, daily oral administration of grapiprant, a novel drug for treatment of osteoarthritic pain and inflammation, in healthy dogs.
Rausch-Derra LC; Huebner M; Rhodes L
Am J Vet Res; 2015 Oct; 76(10):853-9. PubMed ID: 26413822
[TBL] [Abstract][Full Text] [Related]
27. Post-operative analgesic effects of butorphanol or firocoxib administered to dogs undergoing elective ovariohysterectomy.
Camargo JB; Steagall PV; Minto BW; Lorena SE; Mori ES; Luna SP
Vet Anaesth Analg; 2011 May; 38(3):252-9. PubMed ID: 21492391
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit.
De Vito V; Salvadori M; Poapolathep A; Owen H; Rychshanova R; Giorgi M
J Vet Pharmacol Ther; 2017 Oct; 40(5):468-475. PubMed ID: 27925221
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of grapiprant, a novel EP4 antagonist: receptor binding, efficacy in a rodent postoperative pain model, and a dose estimation for controlling pain in dogs.
Nagahisa A; Okumura T
J Vet Pharmacol Ther; 2017 Jun; 40(3):285-292. PubMed ID: 27597397
[TBL] [Abstract][Full Text] [Related]
30. Grapiprant: A snapshot of the current knowledge.
Sartini I; Giorgi M
J Vet Pharmacol Ther; 2021 Sep; 44(5):679-688. PubMed ID: 34057218
[TBL] [Abstract][Full Text] [Related]
31. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
Cook VL; Meyer CT; Campbell NB; Blikslager AT
Am J Vet Res; 2009 Aug; 70(8):992-1000. PubMed ID: 19645580
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of cyclo-oxygenase inhibition by two commercially available firocoxib products in horses.
Barton MH; Paske E; Norton N; King D; Giguère S; Budsberg S
Equine Vet J; 2014 Jan; 46(1):72-5. PubMed ID: 23662599
[TBL] [Abstract][Full Text] [Related]
33. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis.
McCann ME; Andersen DR; Zhang D; Brideau C; Black WC; Hanson PD; Hickey GJ
Am J Vet Res; 2004 Apr; 65(4):503-12. PubMed ID: 15077695
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of orally administered gabapentin in horses with chronic thoracic limb lameness.
Young JM; Schoonover MJ; Kembel SL; Taylor JD; Bauck AG; Gilliam LL
Vet Anaesth Analg; 2020 Mar; 47(2):259-266. PubMed ID: 31980368
[TBL] [Abstract][Full Text] [Related]
35. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
[TBL] [Abstract][Full Text] [Related]
36. Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs.
Cross AR; Budsberg SC; Keefe TJ
Am J Vet Res; 1997 Jun; 58(6):626-31. PubMed ID: 9185970
[TBL] [Abstract][Full Text] [Related]
37. Correlation of prostaglandin E2 concentrations in synovial fluid with ground reaction forces and clinical variables for pain or inflammation in dogs with osteoarthritis induced by transection of the cranial cruciate ligament.
Trumble TN; Billinghurst RC; McIlwraith CW
Am J Vet Res; 2004 Sep; 65(9):1269-75. PubMed ID: 15478776
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report.
Fuertes-Recuero M; Vázquez-Fernández E; Lizasoain-Sánz G; Arroba-Alonso A; Sánchez-López A; Martínez-de-Merlo E; Suárez-Redondo M; Ortiz-Diez G
Vet Res Commun; 2024 Jun; 48(3):1921-1927. PubMed ID: 38453822
[TBL] [Abstract][Full Text] [Related]
39. Analgesic efficacy of oral firocoxib in ovariohysterectomized cats.
Phuwapattanachart P; Thengchaisri N
J Vet Sci; 2017 Jun; 18(2):175-182. PubMed ID: 27515266
[TBL] [Abstract][Full Text] [Related]
40. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia.
McCann ME; Rickes EL; Hora DF; Cunningham PK; Zhang D; Brideau C; Black WC; Hickey GJ
Am J Vet Res; 2005 Jul; 66(7):1278-84. PubMed ID: 16111170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
